Publications by authors named "Reuschel E"

Cohesin shapes the chromatin architecture, including enhancer-promoter interactions. Its components, especially STAG2, but not its paralog STAG1, are frequently mutated in myeloid malignancies. To elucidate the underlying mechanisms of leukemogenesis, we comprehensively characterized genetic, transcriptional, and chromatin conformational changes in acute myeloid leukemia (AML) patient samples.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how the SARS-CoV-2 pandemic affected breastfeeding practices and hospital management for new mothers in Germany and Austria.
  • It combines data from a large cohort of parent-neonate pairs infected with the virus and surveys from hospital physicians to analyze breastfeeding outcomes.
  • Results show high rates of breastfeeding with mothers' milk (93.7%), although challenges like maternal COVID-19 severity and ICU treatment decreased breastfeeding rates; maintaining supportive practices like rooming-in helped sustain these rates during the pandemic.
View Article and Find Full Text PDF

Background: Pregnancy can trigger or aggravate the risk for life-threating arrhythmias in cardiac diseases. Pregnancy is associated with reluctance for implantable cardioverter-defibrillators (ICD) due to concerns about radiation. Thus, the wearable cardioverter-defibrillator (WCD) might be an option during pregnancy.

View Article and Find Full Text PDF

The enhanced transmissibility and immune evasion associated with emerging SARS-CoV-2 variants demands the development of next-generation vaccines capable of inducing superior protection amid a shifting pandemic landscape. Since a portion of the global population harbors some level of immunity from vaccines based on the original Wuhan-Hu-1 SARS-CoV-2 sequence or natural infection, an important question going forward is whether this immunity can be boosted by next-generation vaccines that target emerging variants while simultaneously maintaining long-term protection against existing strains. Here, we evaluated the immunogenicity of INO-4800, our synthetic DNA vaccine candidate for COVID-19 currently in clinical evaluation, and INO-4802, a next-generation DNA vaccine designed to broadly target emerging SARS-CoV-2 variants, as booster vaccines in nonhuman primates.

View Article and Find Full Text PDF

HIV Envelope (Env) is the main vaccine target for induction of neutralizing antibodies. Stabilizing Env into native-like trimer (NLT) conformations is required for recombinant protein immunogens to induce autologous neutralizing antibodies(nAbs) against difficult to neutralize HIV strains (tier-2) in rabbits and non-human primates. Immunizations of mice with NLTs have generally failed to induce tier-2 nAbs.

View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may target epitopes that reduce durability or increase the potential for escape from vaccine-induced immunity. Using synthetic vaccinology, we have developed rationally immune-focused SARS-CoV-2 Spike-based vaccines. Glycans can be employed to alter antibody responses to infection and vaccines.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses the safety and immune response durability of the DNA vaccine INO-4800 against COVID-19, which is crucial as new vaccines are needed urgently.
  • Conducted on 120 healthy adults, the trial tested three dosage strengths (0.5 mg, 1.0 mg, and 2.0 mg) and showed that INO-4800 was well tolerated, with mostly mild side effects and no serious adverse events.
  • The vaccine generated a strong antibody response that lasted for at least 6 months, and increased immune responses were noted after a booster dose, particularly at the highest dosage, supporting further development of INO-4800 for vaccination against COVID-19.
View Article and Find Full Text PDF
Article Synopsis
  • Emerging SARS-CoV-2 variants are concerning due to their increased ability to infect different hosts, cause illness, and evade vaccine-induced immunity.
  • Vaccinated subjects with the DNA vaccine INO-4800 showed neutralizing antibodies against all variants, although responses were lower for the B.1.351 variant.
  • T cell responses (specifically IFNγ) remained strong across all variants, indicating robust cellular immunity.
View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic global impact on public health and social and economic infrastructures. Here, we assess the immunogenicity and anamnestic protective efficacy in rhesus macaques of an intradermal (i.d.

View Article and Find Full Text PDF

A distinct group of colorectal carcinomas (CRCs) referred to as the "CpG island methylator phenotype" (CIMP) shows an extremely high incidence of de novo DNA methylation and may share common pathological, clinical or molecular features. However, there is limited consensus about which CpG islands (CGIs) define a CIMP, particularly in microsatellite stable (MSS) carcinomas. To study this phenotype in a systematic manner, we analyzed genome-wide CGI DNA methylation profiles of 19 MSS CRC using methyl-CpG immunoprecipitation (MCIp) and hybridization on 244K CGI oligonucleotide microarrays, determined KRAS and BRAF mutation status and compared disease-related DNA methylation changes to chromosomal instability as detected by microarray-based comparative genomic hybridization.

View Article and Find Full Text PDF
Article Synopsis
  • Zika virus infections can lead to serious complications, but there are currently no approved vaccines available.
  • A phase 1 clinical trial tested a synthetic DNA vaccine (GLS-5700) for safety and immune response in 40 participants, using intradermal injections combined with electroporation.
  • Results showed no serious adverse effects and a strong immune response, with antibody production indicating potential effectiveness against ZIKV, as proven by protecting mice from infection.
View Article and Find Full Text PDF

Background: From a public health perspective, effective containment strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be balanced with individual liberties.

Methods: We collected 79 respiratory samples from 59 patients monitored in an outpatient center or in the intensive care unit of the University Hospital Regensburg. We analyzed viral load by quantitative real-time polymerase chain reaction, viral antigen by point-of-care assay, time since onset of symptoms, and the presence of SARS-CoV-2 immunoglobulin G (IgG) antibodies in the context of virus isolation from respiratory specimens.

View Article and Find Full Text PDF

Emerging coronaviruses from zoonotic reservoirs, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been associated with human-to-human transmission and significant morbidity and mortality. Here, we study both intradermal and intramuscular 2-dose delivery regimens of an advanced synthetic DNA vaccine candidate encoding a full-length MERS-CoV spike (S) protein, which induced potent binding and neutralizing antibodies as well as cellular immune responses in rhesus macaques. In a MERS-CoV challenge, all immunized rhesus macaques exhibited reduced clinical symptoms, lowered viral lung load, and decreased severity of pathological signs of disease compared with controls.

View Article and Find Full Text PDF

During pregnancy, infections caused by the gram-positive bacteria (), (), and () are major reasons for preterm labor, neonatal prematurity, meningitis, or sepsis. Here, we propose cytokine responses to bacterial infections by the immature perinatal immune system as central players in the pathogenesis of preterm birth and neonatal sepsis. We aimed to close the gap in knowledge about such cytokine responses by stimulating freshly isolated umbilical blood mononuclear cells (UBMC) with lysates of , , and collected from pregnant women in preterm labor.

View Article and Find Full Text PDF
Article Synopsis
  • A new DNA vaccine (INO-4800) targeting SARS-CoV-2's spike protein was tested for safety and immune response in a trial involving 40 participants divided into two dosage groups (1.0 mg and 2.0 mg).
  • The trial observed minimal adverse effects, with only 6 mild reactions in 5 people and no serious side effects reported, while 95% of participants developed a strong immune response by week 6.
  • By week 8, the vaccine showed promising results with significant T cell responses, indicating that INO-4800 is safe and potentially effective for inducing immunity against COVID-19.
View Article and Find Full Text PDF
Article Synopsis
  • - Powassan virus (POWV) is a tick-borne disease in North America that can cause severe neurological issues and has increased over 300% in incidence in the last 16 years, yet there are no available vaccines.
  • - A novel synthetic DNA vaccine called POWV-SEV was developed, targeting key genes of the virus and successfully eliciting strong immune responses in mice with minimal cross-reactivity to other flaviviruses.
  • - The immune responses from POWV-SEV closely resemble those from naturally infected patients, and the vaccine showed effectiveness in protecting mice from POWV-related diseases in lethal challenge tests.
View Article and Find Full Text PDF

evere cute espiratory yndrome ronairus (SARS-CoV-2) has caused a global pandemic of COVID-19, resulting in cases of mild to severe respiratory distress and significant mortality. The global outbreak of this novel coronavirus has now infected >20 million people worldwide, with >5 million cases in the United States (11 August 2020). The development of diagnostic and research tools to determine infection and vaccine efficacy is critically needed.

View Article and Find Full Text PDF

Maternal obesity and excessive gestational weight gain (GWG) affect the outcomes of women and their offspring. Our aim was to evaluate population-based data from Germany. Data from 583 633/791 514 mother-child pairs obtained from the perinatal database in Hesse for the period from 2000 to 2015 were used after excluding incomplete or non-plausible datasets.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 is the virus responsible for the COVID-19 pandemic, and currently, there is no vaccine to combat it.
  • Researchers have developed a synthetic DNA vaccine called INO-4800, targeting the Spike protein of SARS-CoV-2, building on previous work with the MERS coronavirus.
  • Initial tests in mice and guinea pigs show that INO-4800 generates strong immune responses, including neutralizing antibodies, marking it as a potential candidate for further development as a COVID-19 vaccine.
View Article and Find Full Text PDF

Promyelocytic leukemia (PML) bodies are nuclear organelles implicated in intrinsic and innate antiviral defense. The eponymous PML proteins, central to the self-organization of PML bodies, and other restriction factors found in these organelles are common targets of viral antagonism. The 72-kDa immediate-early protein 1 (IE1) is the principal antagonist of PML bodies encoded by the human cytomegalovirus (hCMV).

View Article and Find Full Text PDF

The need for a malaria vaccine is indisputable. A single vaccine for pre-erythrocytic stages targeting the major sporozoite antigen circumsporozoite protein (CSP) has had partial success. Additionally, CD8+ T cells targeting liver-stage (LS) antigens induced by live attenuated sporozoite vaccines were associated with protection in human challenge experiments.

View Article and Find Full Text PDF

Significant concerns have arisen over the past 3 y from the increased global spread of the mosquito-borne flavivirus, Zika. Accompanying this spread has been an increase in cases of the devastating birth defect microcephaly as well as of Guillain-Barré syndrome in adults in many affected countries. Currently there is no vaccine or therapy for this infection; however, we sought to develop a combination approach that provides more rapid and durable protection than traditional vaccination alone.

View Article and Find Full Text PDF

This position paper describes clinically important, practical aspects of cervical pessary treatment. Transvaginal ultrasound is standard for the assessment of cervical length and selection of patients who may benefit from pessary treatment. Similar to other treatment modalities, the clinical use and placement of pessaries requires regular training.

View Article and Find Full Text PDF

Inflammatory immune responses induced by lipopolysaccharides (LPS) of gram-negative bacteria play an important role in the pathogenesis of preterm labor and delivery, and in neonatal disorders. To better characterize LPS-induced inflammatory response, we determined the cytokine profile of umbilical cord blood mononuclear cells (UBMC) stimulated with LPS of seven vaginal gram-negative bacteria commonly found in pregnant women with preterm labor and preterm rupture of membrane. UBMC from ten newborns of healthy volunteer mothers were stimulated with purified LPS of Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Proteus mirabilis, Acinetobacter calcoaceticus, Citrobacter freundii, and Pseudomonas aeruginosa.

View Article and Find Full Text PDF